The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human phase 1 study of SPH4336, a novel cyclin-dependent kinase 4/6 inhibitor, in patients with advanced solid tumors.
 
Yong-Sheng Wang
No Relationships to Disclose
 
Yu Jiang
Speakers' Bureau - Chia Tai Tianqing Pharmaceutical Group; MSD; Novartis; Roche; Shanghai Junshi BioSciences
 
Meili Sun
No Relationships to Disclose
 
Xu Liang
No Relationships to Disclose
 
Huiping Li
No Relationships to Disclose